Novartis AG (VIE:NOVN)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of EUR 217.42 billion. The enterprise value is 237.12 billion.

Market Cap	217.42B
Enterprise Value	237.12B

Important Dates

The last earnings date was Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	1.92B
Shares Outstanding	n/a
Shares Change (YoY)	-3.84%
Shares Change (QoQ)	-1.02%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.42%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 17.72 and the forward PE ratio is 15.10.

PE Ratio	17.72
Forward PE	15.10
PS Ratio	4.53
PB Ratio	5.70
P/TBV Ratio	n/a
P/FCF Ratio	13.03
P/OCF Ratio	12.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.88, with an EV/FCF ratio of 14.21.

EV / Earnings	19.33
EV / Sales	4.86
EV / EBITDA	10.88
EV / EBIT	13.41
EV / FCF	14.21

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.

Current Ratio	0.88
Quick Ratio	0.58
Debt / Equity	0.72
Debt / EBITDA	1.27
Debt / FCF	1.64
Interest Coverage	18.35

Financial Efficiency

Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.

Return on Equity (ROE)	32.62%
Return on Assets (ROA)	12.13%
Return on Invested Capital (ROIC)	16.78%
Return on Capital Employed (ROCE)	27.17%
Revenue Per Employee	633,157
Profits Per Employee	161,659
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 1.74 billion in taxes.

Income Tax	1.74B
Effective Tax Rate	12.40%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	109.43
200-Day Moving Average	n/a
Relative Strength Index (RSI)	63.40
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of EUR 48.05 billion and earned 12.27 billion in profits. Earnings per share was 6.22.

Revenue	48.05B
Gross Profit	36.63B
Operating Income	17.43B
Pretax Income	13.99B
Net Income	12.27B
EBITDA	21.24B
EBIT	17.43B
Earnings Per Share (EPS)	6.22

Balance Sheet

The company has 8.24 billion in cash and 27.29 billion in debt, giving a net cash position of -19.05 billion.

Cash & Cash Equivalents	8.24B
Total Debt	27.29B
Net Cash	-19.05B
Net Cash Per Share	n/a
Equity (Book Value)	38.14B
Book Value Per Share	19.69
Working Capital	-3.24B

Cash Flow

In the last 12 months, operating cash flow was 17.96 billion and capital expenditures -1.28 billion, giving a free cash flow of 16.68 billion.

Operating Cash Flow	17.96B
Capital Expenditures	-1.28B
Free Cash Flow	16.68B
FCF Per Share	n/a

Margins

Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.

Gross Margin	76.25%
Operating Margin	36.29%
Pretax Margin	29.13%
Profit Margin	25.53%
EBITDA Margin	44.21%
EBIT Margin	36.29%
FCF Margin	34.73%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	54.32%
Buyback Yield	3.84%
Shareholder Yield	3.84%
Earnings Yield	5.64%
FCF Yield	7.67%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.

Altman Z-Score	3.8
Piotroski F-Score	7